High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes
To access this article, please choose from the options below
PII: S0306-9877(97)90682-4
doi:10.1054/mehy.1997.0682
© 1999 Harcourt Publishers Ltd. All rights reserved.
